Memantine vs Palivizumab

## Memantine vs Palivizumab: Overview

This comparison examines the pharmacological differences between **Memantine** and **Palivizumab**.

## Mechanism of Action

**Memantine**: Non-competitive NMDA receptor antagonist.

## Pharmacokinetics

**Half-life**: Memantine — 60-80 hours; Palivizumab — N/A.

## Chemical Properties

**Molecular Formula**: Memantine — C12H21N; Palivizumab — N/A.

**Molecular Weight**: Memantine — 179.3080 g/mol; Palivizumab — N/A.

**Type**: Memantine — Small molecule; Palivizumab — Antibody.